NMR-based identification of peptides that specifically recognize the d-arm of tRNA.

[1]  J. Puglisi,et al.  Design of a cyclic peptide that targets a viral RNA. , 2003, Journal of the American Chemical Society.

[2]  Horst Kessler,et al.  NMR-based screening technologies. , 2003, Drug discovery today.

[3]  P. Hajduk,et al.  Integration of NMR and high-throughput screening. , 2002, Combinatorial chemistry & high throughput screening.

[4]  Johan Schultz,et al.  Site-selective labeling strategies for screening by NMR. , 2002, Combinatorial chemistry & high throughput screening.

[5]  C. Tisné,et al.  Optimisation of a peptide library for screening specific RNA ligands by flow-injection NMR. , 2002, Combinatorial chemistry & high throughput screening.

[6]  Wyss Df,et al.  NMR-based approaches for lead discovery. , 2002 .

[7]  P. Roller,et al.  Cyclization strategies in peptide derived drug design. , 2002, Current topics in medicinal chemistry.

[8]  B. Roques,et al.  Heteronuclear NMR studies of the interaction of tRNA3Lys with HIV-1 nucleocapsid protein , 2001 .

[9]  C. Ehresmann,et al.  NMR and biochemical characterization of recombinant human tRNA(Lys)3 expressed in Escherichia coli: identification of posttranscriptional nucleotide modifications required for efficient initiation of HIV-1 reverse transcription. , 2000, RNA.

[10]  E. De Clercq,et al.  The HIV‐1 Reverse Transcription (RT) Process as Target for RT Inhibitors , 2000, Medicinal research reviews.

[11]  W. C. Still,et al.  Inhibition of gene expression in human cells through small molecule-RNA interactions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Hajduk,et al.  NMR-based screening in drug discovery , 1999, Quarterly Reviews of Biophysics.

[13]  M A Wainberg,et al.  HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. , 1999, Archives of biochemistry and biophysics.

[14]  J. Mak,et al.  Primer tRNAs for reverse transcription , 1997, Journal of virology.

[15]  J. Karn,et al.  An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  L. Kay,et al.  α Helix-RNA Major Groove Recognition in an HIV-1 Rev Peptide-RRE RNA Complex , 1996, Science.

[17]  N. Wallis,et al.  Heteronuclear NMR studies of the interactions of 15N-labeled methionine-specific transfer RNAs with methionyl-tRNA transformylase. , 1995, Biochemistry.

[18]  F. Dardel,et al.  MC-Fit: using Monte-Carlo methods to get accurate confidence limits on enzyme parameters , 1994, Comput. Appl. Biosci..

[19]  P. Moore,et al.  Assignment of NH resonances in nucleic acids using natural abundance 15N‐1H correlation spectroscopy with spin‐echo and gradient pulses , 1993, FEBS letters.

[20]  Y. Mechulam,et al.  Fast purification of a functional elongator tRNAmet expressed from a synthetic gene in vivo. , 1988, Nucleic acids research.

[21]  Pierre Plateau,et al.  Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .

[22]  Martin Vogtherr,et al.  NMR-based screening methods for lead discovery. , 2003, EXS.

[23]  M. Senior,et al.  NMR-based approaches for lead discovery. , 2002, Current opinion in drug discovery & development.

[24]  C. Ehresmann,et al.  tRNAs as primer of reverse transcriptases. , 1995, Biochimie.